Advertisement
U.S. markets open in 8 hours 38 minutes
  • S&P Futures

    5,209.50
    -5.25 (-0.10%)
     
  • Dow Futures

    39,215.00
    -8.00 (-0.02%)
     
  • Nasdaq Futures

    18,185.50
    -46.00 (-0.25%)
     
  • Russell 2000 Futures

    2,048.40
    -1.40 (-0.07%)
     
  • Crude Oil

    82.59
    -0.13 (-0.16%)
     
  • Gold

    2,163.60
    -0.70 (-0.03%)
     
  • Silver

    25.30
    +0.03 (+0.14%)
     
  • EUR/USD

    1.0872
    -0.0005 (-0.04%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2717
    -0.0012 (-0.09%)
     
  • USD/JPY

    150.0180
    +0.9200 (+0.62%)
     
  • Bitcoin USD

    65,190.80
    -3,282.38 (-4.79%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,733.31
    -7.09 (-0.02%)
     

Metromile Integrates Verisk's LightSpeed Auto Platform To Simplify Consumer Experience

  • Metromile Inc (NASDAQ: MILE) announced an integration with Verisk Analytics, Inc's (NASDAQ: VRSK) LightSpeed Auto to simplify the consumer buying experience, increase speed to bind and conversion rates, and lower acquisition costs.

  • LightSpeed Auto is a digital underwriting platform that combines extensive data resources and predictive analytics from Verisk. It enables insurers to shorten application questionnaires and allows for more than 400 underwriting data elements to be delivered upfront at the point of quote.

  • Digital solutions eliminate hidden costs of outdated insurance models; with LightSpeed Auto, underwriting attributes, including data on drivers, vehicles, coverages, licensing, violations, and losses, can now be delivered in real-time and in a single transaction.

  • Price Action: VRSK shares are trading lower by 0.21% at $197.10, and MILE higher by 4.29% at $4.26 on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement